Mindswift Pharmaceuticals Private Limited
About Mindswift Pharmaceuticals Private Limited
Data last updated:
Mindswift Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 27 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24239PN2019PTC184377. Its GSTIN is 27AAMCM6960A1ZD (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mayur Mohan Bandal and Arati Mayur Bandal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.97 Lakh, a growth of 35% compared to the previous year. For the same year it recorded a net profit of ₹75,500 (net margin 5.4%) and EBITDA of ₹1.49 Lakh (EBITDA margin 10.7%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 78% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Mindswift Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its e-mail address is in the company report.
- Email
- Social Media
- Registered AddressS. No. 56/4/1 Office No. 319, Vision One Phase II Tathawade, Pune, Maharashtra, India – 411033
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Mindswift Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mindswift Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Mindswift Pharmaceuticals Private Limited, buy the company report.
Financials of Mindswift Pharmaceuticals Private Limited
FY 2025 filings availableMindswift Pharmaceuticals Private Limited reported revenue of ₹13.97 Lakh (up 35% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 78% over five years, including 35% growth in the latest year. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.49 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹75,500 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.7% | ||||
| Net Profit Margin | 5.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mindswift Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mindswift Pharmaceuticals Private Limited
Mindswift Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arati Mayur Bandal | Additional Director | 19 Aug 2023 | 3 Years 2 Months | Current |
| Mayur Mohan Bandal | Director | 27 May 2019 | 7 Years 5 Months | Current |
Legal cases
No court or tribunal cases involving Mindswift Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mindswift Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mindswift Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAMCM6960A1ZD | Maharashtra | Active | 01 Jul 2019 |
To see the full GST registrations and return filing status of Mindswift Pharmaceuticals Private Limited, buy the company report.
Recent activity
Mindswift Pharmaceuticals Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Pallavi Rajendra Mhetre ceased to be Director on 21 Aug 2023.
Frequently asked questions
Mindswift Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 27 May 2019 (7+ years old) and is registered under CIN U24239PN2019PTC184377.
Mindswift Pharmaceuticals has 2 current directors:
- Arati Mayur Bandal - Additional Director
- Mayur Mohan Bandal - Director
The latest financial statements of Mindswift Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Mindswift Pharmaceuticals is 27AAMCM6960A1ZD, registered in Maharashtra.
The CIN (Corporate Identification Number) of Mindswift Pharmaceuticals is U24239PN2019PTC184377. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mindswift Pharmaceuticals was incorporated on 27 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Pune.
Pallavi Rajendra Mhetre ceased to be Director on 21 Aug 2023. Arati Mayur Bandal was appointed as Additional Director on 19 Aug 2023. Mayur Mohan Bandal was appointed as Director on 27 May 2019.
The registered office of Mindswift Pharmaceuticals is at S. No. 5641 Office No. 319, Vision One Phase II Tathawade, Pune, Maharashtra, India – 411033.
Mindswift Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
The compliance status of Mindswift Pharmaceuticals is compliant as of 07 August 2026. The company is actively filing with the Registrar of Companies.